Centiva Capital’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,200
Closed -$3.5M 2232
2024
Q3
$3.5M Buy
20,200
+4,900
+32% +$832K 0.07% 241
2024
Q2
$2.52M Sell
15,300
-60,000
-80% -$9.81M 0.04% 312
2024
Q1
$12.2M Buy
75,300
+20,800
+38% +$3.26M 0.3% 40
2023
Q4
$7.99M Buy
54,500
+14,500
+36% +$2.15M 0.19% 80
2023
Q3
$5.83M Buy
40,000
+10,000
+33% +$1.53M 0.13% 141
2023
Q2
$4.55M Buy
30,000
+4,400
+17% +$663K 0.1% 211
2023
Q1
$3.81M Buy
25,600
+4,600
+22% +$658K 0.09% 238
2022
Q4
$3.18M Sell
21,000
-5,800
-22% -$813K 0.09% 230
2022
Q3
$3.38M Buy
26,800
+25,800
+2,580% +$3.67M 0.06% 224
2022
Q2
$144K Sell
1,000
-20,500
-95% -$3.08M ﹤0.01% 1359
2022
Q1
$3.29M Buy
21,500
+21,100
+5,275% +$3.3M 0.06% 276
2021
Q4
$65K Buy
+400
New +$59.4K ﹤0.01% 1071
2019
Q1
Sell
-12,600
Closed -$1.16M 359
2018
Q4
$1.16M Buy
+12,600
New +$1.13M 0.09% 129

Other funds holding PG

Centiva Capital's PG Position: Q2 2026 in Review

Centiva Capital sold out of Procter & Gamble (PG) in Q2 2026, closing a stake of 5,643 shares — an estimated $815K sold.

Centiva Capital first reported a position in PG in Q4 2019 and held it in 19 quarters. The position peaked at $8.46M in Q2 2023. 4,006 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Centiva Capital reported no remaining Procter & Gamble position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 5,643 Procter & Gamble shares in Q2 2026, an estimated $815K.
  • Centiva Capital first reported a position in Procter & Gamble in Q4 2019 and held it in 19 quarters.
  • Centiva Capital's Procter & Gamble position peaked at $8.46M in Q2 2023.
  • 4,006 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.